Authors: Shishova, YV Yurchenko, OV Khromyak, VN Sidorenko, SP Chekhun, VF

Citation: Yv. Shishova et al., Cisplatin resistance associated with hypersensitivity to CD95-mediated apoptosis in epidermoid carcinoma cell KB/DDP5 subline, EXP ONCOL, 21(2), 1999, pp. 141-145

Authors: Stasyk, TV Antonyuk, VA Yakymovych, MY Yakymovych, IA Yanish, YV Shishova, YV Shlyakhovenko, VA Chekhun, VF Stoika, RS Lutsik-Kordovsky, MD

Citation: Tv. Stasyk et al., A comparative study of cell surface glycosyl determinants in cisplatin-sensitive and resistant L1210 murine leukemia cells, EXP ONCOL, 20(3-4), 1998, pp. 204-209

Authors: Chekhun, VF Shishova, YV Yurchenko, OV Shlapatskaya, LN Mikhalap, SV Berdova, AG Sidorenko, SP Kulik, GI Gluzman, DF

Citation: Vf. Chekhun et al., Synergistic cytotoxic effect of cisplatin and monoclonal anti-Fas IPO-4 antibodies on human epidermoid carcinoma cell line KB, EXP ONCOL, 20(3-4), 1998, pp. 210-216

Authors: Stoika, RS Yakymovych, MY Yakymovych, IA Shishova, YV Chekhun, VF

Citation: Rs. Stoika et al., Murine L1210 leukemia cells resistant to cis-diaminedichloroplatinum(II) action are also refractory to beta 1-induced growth inhibition, EXP ONCOL, 20(3-4), 1998, pp. 256-258